ATE323103T1 - Proteinmarker für ösophaguskrebs - Google Patents

Proteinmarker für ösophaguskrebs

Info

Publication number
ATE323103T1
ATE323103T1 AT97927689T AT97927689T ATE323103T1 AT E323103 T1 ATE323103 T1 AT E323103T1 AT 97927689 T AT97927689 T AT 97927689T AT 97927689 T AT97927689 T AT 97927689T AT E323103 T1 ATE323103 T1 AT E323103T1
Authority
AT
Austria
Prior art keywords
protein marker
esophagus cancer
proteins
tissue
ipg
Prior art date
Application number
AT97927689T
Other languages
English (en)
Inventor
Samir M Hanash
David G Beer
Rork Kuick
Robert Hinderer
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan filed Critical Univ Michigan
Application granted granted Critical
Publication of ATE323103T1 publication Critical patent/ATE323103T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT97927689T 1996-05-30 1997-05-29 Proteinmarker für ösophaguskrebs ATE323103T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1865996P 1996-05-30 1996-05-30

Publications (1)

Publication Number Publication Date
ATE323103T1 true ATE323103T1 (de) 2006-04-15

Family

ID=21789115

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97927689T ATE323103T1 (de) 1996-05-30 1997-05-29 Proteinmarker für ösophaguskrebs

Country Status (10)

Country Link
EP (1) EP0950062B1 (de)
JP (1) JP4993799B2 (de)
AT (1) ATE323103T1 (de)
AU (1) AU739306B2 (de)
CA (1) CA2264963C (de)
DE (1) DE69735676T2 (de)
DK (1) DK0950062T3 (de)
ES (1) ES2258278T3 (de)
NZ (1) NZ333075A (de)
WO (1) WO1997045445A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002951153A0 (en) * 2002-09-02 2002-09-19 Proteome Systems Intellectual Property Pty Ltd An electrophoresis gel having improved swelling properties
US20080219981A1 (en) * 2004-03-29 2008-09-11 Hideki Shimada Diagnostic Kit for Solid Cancer and Medicament for Solid Cancer Therapy
DE602005023021D1 (de) 2004-06-02 2010-09-30 Tss Biotech Inc Neues polypeptid mit eignung zur diagnose und behandlung von krebs
GB0521521D0 (en) * 2005-10-21 2005-11-30 Medical Res Council Diagnostic methods and kits
WO2009142257A1 (ja) 2008-05-21 2009-11-26 東レ株式会社 食道ガン判定用組成物及び方法

Also Published As

Publication number Publication date
EP0950062A4 (de) 2000-07-05
EP0950062A1 (de) 1999-10-20
AU3208997A (en) 1998-01-05
CA2264963A1 (en) 1997-12-04
ES2258278T3 (es) 2006-08-16
JP2000511536A (ja) 2000-09-05
DK0950062T3 (da) 2006-08-14
DE69735676D1 (de) 2006-05-24
CA2264963C (en) 2010-03-09
NZ333075A (en) 2000-05-26
DE69735676T2 (de) 2006-10-19
EP0950062B1 (de) 2006-04-12
AU739306B2 (en) 2001-10-11
WO1997045445A1 (en) 1997-12-04
JP4993799B2 (ja) 2012-08-08

Similar Documents

Publication Publication Date Title
DK0961780T3 (da) Proteinmarkörer for lungecancer og anvendelse deraf
WO1998035985B1 (en) Protein markers for lung cancer and use thereof
PT991421E (pt) Deteccao e modulacao das iap e naip para o diagnostico e tratamento de doenca proliferativa
CY1106382T1 (el) Αντισωματα anti-vegf
SE8900247D0 (sv) Amphiregulin: a novel bifunctional growth modulating glycoprotein
TR199902818T2 (xx) Be�eri kullan�m i�in antikorlar ve be�eri kullan�m i�in antikorlar olu�turmak i�in y�ntemler.
BR0315666A (pt) Dna de a34 e a33 do tipo 3, proteìnas, seus anticorpos e métodos de tratamento usando os mesmos
DE60134178D1 (de) Trp8 krebsmarker
ATE347360T1 (de) Verfahren zur induktion von krebszellentod und tumorregression
DE60033555D1 (de) Verfahren und zusammestellungen zum nachweis und behandlung von brustkrebs, beruhend auf brustkrebs-assoziierten polypeptiden
PT1650219E (pt) Homólogos de toll humana
WO2004000094A3 (en) Predictive markers in cancer therapy
ATE229073T1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
DE69229394D1 (de) Zusammensetzungen und methoden zur behandlung von kleinzell und nicht-kleinzell lungenkrebsen
ES2141249T3 (es) Procedimiento para la identificacion de celulas humanas y animales que presentan la capacidad para una proliferacion ilimitada o para una formacion de tumores.
EP0772625A4 (de) Oligonukleoside und verfahren zur hemmung des tumorwachstums, der invasion und der metastasenbildung
ATE323103T1 (de) Proteinmarker für ösophaguskrebs
DE60044350D1 (de) Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs
EP0833948A4 (de) Für den dickdarm spezifische gene und proteine
DE69636041D1 (de) Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen
BR0012301A (pt) Inibidores de crescimento de células epiteliais
WO2001059114A3 (en) Tumor suppressor gene, p47ing3
WO2003054008A3 (en) Mammalian simp protein, gene sequence and uses thereof in cancer therapy

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties